LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat lung cancers: trial tests pill to slow tumor growth
Disease control OngoingThis study is testing an oral drug called Abemaciclib for people with specific, aggressive types of lung cancer that have stopped responding to or returned after standard chemotherapy. The goal is to see if the drug can safely shrink tumors and slow the cancer's progression. It i…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Immunotherapy-Chemo combo trial aims to extend lives in Tough-to-Treat lung cancer
Disease control OngoingThis study is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy helps people with advanced large-cell neuroendocrine lung cancer live longer. It involves 67 adults with this specific cancer who haven't had prior treatment for their advanced disea…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC